CD80 and neoplasm: Consistently, our in vivo data show that Poly6 vaccination also led to a strong enhancement of CD40 expression in tumor infiltrated DCs (Figure 4C) compared to other DC costimulatory molecules (CD80, CD86, and MHC class II).